Coagulation is a host defense system that limits the spread of pathogens. Coagulation proteases, such as thrombin, also activate cells by cleaving PARs. In this study, we analyzed the role of PAR-1 in coxsackievirus B3–induced (CVB3-induced) myocarditis and influenza A infection. CVB3-infected
Silvio Antoniak, A. Phillip Owens III, Martin Baunacke, Julie C. Williams, Rebecca D. Lee, Alice Weithäuser, Patricia A. Sheridan, Ronny Malz, James P. Luyendyk, Denise A. Esserman, JoAnn Trejo, Daniel Kirchhofer, Burns C. Blaxall, Rafal Pawlinski, Melinda A. Beck, Ursula Rauch, Nigel Mackman
Title and authors | Publication | Year |
---|---|---|
Therapeutic effects of platelet-derived extracellular vesicles on viral myocarditis correlate with biomolecular content
Beetler DJ, Giresi P, Di Florio DN, Fliess JJ, McCabe EJ, Watkins MM, Xu V, Auda ME, Bruno KA, Whelan ER, Kocsis SP, Edenfield BH, Walker SA, Macomb LP, Keegan KC, Jain A, Morales-Lara AC, Chekuri I, Hill AR, Farres H, Wolfram J, Behfar A, Stalboerger PG, Terzic A, Cooper LT Jr, Fairweather D |
Frontiers in Immunology | 2025 |
Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors
Lotke R, Petersen M, Sauter D |
Viruses | 2024 |
Unveiling the Role of PAR 1: A Crucial Link with Inflammation in Diabetic Subjects with COVID-19
Singh R, Singh V, Ahmad MA, Pasricha C, Kumari P, Singh TG, Kaur R, Mujwar S, Wani TA, Zargar S |
Pharmaceuticals | 2024 |
Major Group-B Enterovirus populations deleted in the noncoding 5' region of genomic RNA modulate activation of the type I interferon pathway in cardiomyocytes and induce myocarditis.
Callon D, Glenet M, Lebreil AL, Heng L, Bouland N, Fichel C, Fornes P, Andreoletti L, Berri F |
PLoS pathogens | 2024 |
The Role of ACE2 Receptor and Its Polymorphisms in COVID-19 Infection and Severity and Its Association with Lipid Profile, Thrombin, and D-Dimer Levels in Iraqi Patients: A Cross-Sectional Study.
Hatem BA, Jabir FA |
Biochemical Genetics | 2024 |
Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling
Jannati S, Patnaik R, Banerjee Y |
International Journal of Molecular Sciences | 2024 |
STAT3 Increases CVB3 Replication and Acute Pancreatitis and Myocarditis Pathology via Impeding Nuclear Translocation of STAT1 and Interferon-Stimulated Gene Expression
Liang T, Zhang Z, Bai Z, Xu L, Xu W |
International Journal of Molecular Sciences | 2024 |
Immune mechanisms of group B coxsackievirus induced viral myocarditis
Zhang Y, Zhou X, Chen S, Sun X, Zhou C |
Virulence | 2023 |
An Emerging Role for Type I Interferons as Critical Regulators of Blood Coagulation
Ryan TA, O\u2019Neill LA |
Cells | 2023 |
Role of Coxsackievirus B3-Induced Immune Responses in the Transition from Myocarditis to Dilated Cardiomyopathy and Heart Failure
Yip F, Lai B, Yang D |
International journal of molecular sciences | 2023 |
Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon
Ryan TA, Hooftman A, Rehill AM, Johansen MD, Brien EC, Toller-Kawahisa JE, Wilk MM, Day EA, Weiss HJ, Sarvari P, Vozza EG, Schramm F, Peace CG, Zotta A, Miemczyk S, Nalkurthi C, Hansbro NG, McManus G, O\u2019Doherty L, Gargan S, Long A, Dunne J, Cheallaigh CN, Conlon N, Carty M, Fallon PG, Mills KH, Creagh EM, Donnell JS, Hertzog PJ, Hansbro PM, McLoughlin RM, Wygrecka M, Preston RJ, Zasłona Z, Neill LA |
Nature Communications | 2023 |
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis
Koudriavtseva T, Lorenzano S, Cellerino M, Truglio M, Fiorelli M, Lapucci C, D\u2019Agosto G, Conti L, Stefanile A, Zannino S, Filippi MM, Cortese A, Piantadosi C, Maschio M, Maialetti A, Galiè E, Salvetti M, Inglese M |
Frontiers in immunology | 2023 |
New insight into the agonism of protease-activated receptors as an immunotherapeutic strategy.
Jiang Y, Lu L |
The Journal of biological chemistry | 2023 |
Reconstituted extracellular vesicles from human platelets decrease viral myocarditis in mice
Beetler DJ, Bruno KA, Watkins MM, Xu V, Chekuri I, Giresi P, Di Florio DN, Whelan ER, Edenfield BH, Walker SA, Morales-Lara AC, Hill AR, Jain A, Auda ME, Macomb LP, Shapiro KA, Keegan KC, Wolfram J, Behfar A, Stalboerger PG, Terzic A, Farres H, Cooper LT Jr, Fairweather D |
Small (Weinheim an Der Bergstrasse, Germany) | 2023 |
Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling
Zelaya H, Grunz K, Nguyen TS, Habibi A, Witzler C, Reyda S, Gonzalez-Menendez I, Quintanilla-Martinez L, Bosmann M, Weiler H, Ruf W |
Blood | 2023 |
Activated Protein C Protects against Murine Contact Dermatitis by Suppressing Protease-Activated Receptor 2
M Xue, H Lin, R Zhao, C Fryer, L March, C Jackson |
International journal of molecular sciences | 2022 |
The enzymes in COVID-19: A review
M Alves, L Mahnke, T Macedo, T dos Santos Silva, L Junior |
Biochimie | 2022 |
Hemostatic system and COVID-19 crosstalk: A review of the available evidence
Wifi MN, Morad MA, El Sheemy R, Abdeen N, Afify S, Abdalgaber M, Abdellatef A, Zaghloul M, Alboraie M, El-Kassas M |
World Journal of Methodology | 2022 |
Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
Ryan TA, O'Neill LA |
European Journal of Immunology | 2022 |
Platelet in thrombo-inflammation: Unraveling new therapeutic targets
Sharma S, Tyagi T, Antoniak S |
Frontiers in immunology | 2022 |
Platelets in COVID-19 disease: friend, foe, or both?
Smęda M, Hosseinzadeh Maleki E, Pełesz A, Chłopicki S |
Pharmacological reports : PR | 2022 |
Cytotoxic CD8+ T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial Fibrillation
Friebel J, Witkowski M, Wegner M, Blöbaum L, Lammel S, Schencke PA, Jakobs K, Puccini M, Reißner D, Steffens D, Moos V, Schutheiss HP, Landmesser U, Rauch U |
Cells | 2022 |
Platelet-Mediated NET Release Amplifies Coagulopathy and Drives Lung Pathology During Severe Influenza Infection
SJ Kim, A Carestia, B McDonald, AZ Zucoloto, H Grosjean, RP Davis, M Turk, V Naumenko, S Antoniak, N Mackman, MS Abdul-Cader, MF Abdul-Careem, MD Hollenberg, CN Jenne |
Frontiers in immunology | 2021 |
Advocacy of targeting protease‐activated receptors in severe coronavirus disease 2019
S Subramaniam, W Ruf, M Bosmann |
British Journal of Pharmacology | 2021 |
Cell type-specific roles of PAR1 in Coxsackievirus B3 infection
MF Bode, CM Schmedes, GJ Egnatz, V Bharathi, YM Hisada, D Martinez, T Kawano, A Weithauser, L Rosenfeldt, U Rauch, JS Palumbo, S Antoniak, N Mackman |
Scientific Reports | 2021 |
Host Components That Modulate the Disease Caused by hMPV
NM Gálvez, CA Andrade, GA Pacheco, JA Soto, V Stranger, T Rivera, AE Vásquez, AM Kalergis |
Viruses | 2021 |
The role of protease-activated receptor 1 signaling in CD8 T cell effector functions
H Chen, M Smith, J Herz, T Li, R Hasley, CL Saout, Z Zhu, J Cheng, A Gronda, JA Martina, PM Irusta, T Karpova, DB McGavern, M Catalfamo |
iScience | 2021 |
Sex-Specific Effects of Plastic Caging in Murine Viral Myocarditis
KA Bruno, LP Macomb, AC Morales-Lara, JE Mathews, JA Frisancho, AL Yang, DN Florio, BH Edenfield, ER Whelan, GR Salomon, AR Hill, CC Hewa-Rahinduwage, AJ Scott, HD Greyner, FA Molina, MS Greenaway, GM Cooper, DL Fairweather |
International journal of molecular sciences | 2021 |
PAR1 regulation of CXCL1 expression and neutrophil recruitment to the lung in mice infected with influenza A virus
S Antoniak, K Tatsumi, CM Schmedes, GJ Egnatz, AC Auriemma, V Bharathi, T Stokol, MA Beck, JH Griffin, JS Palumbo, N Mackman |
Journal of Thrombosis and Haemostasis | 2021 |
Molecular Mechanisms of Multi-Organ Failure in COVID-19 and Potential of Stem Cell Therapy
A Bhalerao, S Raut, B Noorani, S Mancuso, L Cucullo |
Cells | 2021 |
Myeloid Protease-Activated Receptor-2 Contributes to Influenza A Virus Pathology in Mice
RC Gunther, V Bharathi, SD Miles, LR Tumey, CM Schmedes, K Tatsumi, MD Bridges, D Martinez, SA Montgomery, MA Beck, E Camerer, N Mackman, S Antoniak |
Frontiers in immunology | 2021 |
Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
J Friebel, E Moritz, M Witkowski, K Jakobs, E Strässler, A Dörner, D Steffens, M Puccini, S Lammel, R Glauben, F Nowak, N Kränkel, A Haghikia, V Moos, HP Schutheiss, SB Felix, U Landmesser, BH Rauch, U Rauch |
Cells | 2021 |
Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability
R Lee, T Kawano, S Grover, V Bharathi, D Martinez, D Cowley, N Mackman, W Bergmeier, S Antoniak |
Journal of Thrombosis and Haemostasis | 2021 |
Polymorphisms in STING Affect Human Innate Immune Responses to Poxviruses
RB Kennedy, IH Haralambieva, IG Ovsyannikova, EA Voigt, BR Larrabee, DJ Schaid, MT Zimmermann, AL Oberg, GA Poland |
Frontiers in immunology | 2020 |
Coagulation and Fibrinolysis in Kidney Graft Rejection
G Stallone, P Pontrelli, F Rascio, G Castellano, L Gesualdo, G Grandaliano |
Frontiers in immunology | 2020 |
Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19
KL Hartshorn |
Frontiers in Cellular and Infection Microbiology | 2020 |
COVID-19 cytokine storm: the interplay between inflammation and coagulation
RJ Jose, A Manuel |
The lancet. Respiratory medicine | 2020 |
Antiviral anticoagulation
EL Pryzdial, MR Sutherland, BH Lin, M Horwitz |
Research and Practice in Thrombosis and Haemostasis | 2020 |
Proteinase‐activated receptor 1: A target for repurposing in the treatment of COVID‐19?
K Sriram, PA Insel |
British Journal of Pharmacology | 2020 |
Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis
RJ José, A Williams, A Manuel, JS Brown, RC Chambers |
European Respiratory Review | 2020 |
Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs
JG Melgaço, DB e Cunha, T Azamor, AM da Silva, LN Tubarão, RB Gonçalves, RQ Monteiro, S Missailidis, PC da Costa Neves, AP Bom, C Cavaliere |
Journal of Immunology Research | 2020 |
Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19
AA Khan, RU Sany, S Islam, AB Islam |
Frontiers in Genetics | 2020 |
Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia
F Taus, G Salvagno, S Canè, C Fava, F Mazzaferri, E Carrara, V Petrova, RM Barouni, F Dima, A Dalbeni, S Romano, G Poli, M Benati, SD Nitto, G Mansueto, M Iezzi, E Tacconelli, G Lippi, V Bronte, P Minuz |
Arteriosclerosis, thrombosis, and vascular biology | 2020 |
Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
KF Aliter, RA Al-Horani |
Cardiovascular Drugs and Therapy | 2020 |
Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection
P Campana, V Parisi, D Leosco, D Bencivenga, FD Ragione, A Borriello |
Cells | 2020 |
Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases
JJ Posma, SP Grover, Y Hisada, AP Owens, S Antoniak, HM Spronk, N Mackman |
Arteriosclerosis, thrombosis, and vascular biology | 2019 |
Virus envelope tissue factor promotes infection in mice
MR Sutherland, AY Simon, I Shanina, MS Horwitz, W Ruf, EL Pryzdial |
Journal of Thrombosis and Haemostasis | 2019 |
Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection
K Tatsumi, CM Schmedes, ER Houston, E Butler, N Mackman, S Antoniak |
Cellular Immunology | 2019 |
BPA Alters Estrogen Receptor Expression in the Heart After Viral Infection Activating Cardiac Mast Cells and T Cells Leading to Perimyocarditis and Fibrosis
KA Bruno, JE Mathews, AL Yang, JA Frisancho, AJ Scott, HD Greyner, FA Molina, MS Greenaway, GM Cooper, A Bucek, AC Morales-Lara, AR Hill, AA Mease, DN Florio, JM Sousou, AC Coronado, AR Stafford, DL Fairweather |
Frontiers in Endocrinology | 2019 |
Cellular and Molecular Events in the Airway Epithelium Defining the Interaction Between House Dust Mite Group 1 Allergens and Innate Defences
J Zhang, J Chen, C Robinson |
International journal of molecular sciences | 2018 |
Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity
S Antoniak, K Tatsumi, CM Schmedes, SP Grover, R Pawlinski, N Mackman |
Journal of Molecular and Cellular Cardiology | 2018 |
The coagulation system in host defense
S Antoniak |
Research and Practice in Thrombosis and Haemostasis | 2018 |
Infectious myocarditis: the role of the cardiac vasculature
L Woudstra, LJ Juffermans, AC van Rossum, HW Niessen, PA Krijnen |
Heart Failure Reviews | 2018 |
A bronchoprotective role for Rgs2 in a murine model of lipopolysaccharide-induced airways inflammation
T George, M Chakraborty, MA Giembycz, R Newton |
Allergy Asthma & Clinical Immunology | 2018 |
Allergen Delivery Inhibitors: A Rationale for Targeting Sentinel Innate Immune Signaling of Group 1 House Dust Mite Allergens through Structure-Based Protease Inhibitor Design
J Zhang, J Chen, GK Newton, TR Perrior, C Robinson |
Molecular pharmacology | 2018 |
Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial
SJ Kent, S Hough, AD Kelleher, MG Law, J Hutchinson, M Catalfarmo, C Lane, JV Baker, S Emery |
The Lancet HIV | 2018 |
Modeling aging in HIV infection in nonhuman primates to address an emerging challenge of the post-ART era
T He, E Falwell, E Brocca-Cofano, I Pandrea |
Current Opinion in Virology | 2017 |
Targeting PAR1: Now What?
R Flaumenhaft, KD Ceunynck |
Trends in Pharmacological Sciences | 2017 |
Cardiac Function Remains Impaired Despite Reversible Cardiac Remodeling after Acute Experimental Viral Myocarditis
PM Becher, F Gotzhein, K Klingel, F Escher, S Blankenberg, D Westermann, D Lindner |
Journal of Immunology Research | 2017 |
Protease-activated receptor 1 inhibition protects mice against thrombin-dependent respiratory syncytial virus and human metapneumovirus infections: PAR1 antagonist protects against RSV and hMPV infections
VB Lê, B Riteau, MC Alessi, C Couture, M Jandrot-Perrus, C Rhéaume, MÈ Hamelin, G Boivin |
British Journal of Pharmacology | 2017 |
Virus–Platelet Associations
Pryzdial EL, Lin BH, Sutherland MR |
Platelets in Thrombotic and Non-Thrombotic Disorders | 2017 |
HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver
Bi-Sen Ding, Catherine H. Liu, Yue Sun, Yutian Chen, Steven Swendeman, Bongnam Jung, Zhongwei cao, Deebly Chavez, Christina Christoffersen, Lars B. Nielsen, Susan Schwab, Shahin Rafii, Timothy Hla |
JCI Insight | 2016 |
Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice
S Antoniak, K Tatsumi, Y Hisada, JJ Milner, SD Neidich, CM Shaver, R Pawlinski, MA Beck, JA Bastarache, N Mackman |
Journal of Thrombosis and Haemostasis | 2016 |
Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of Mmp12
AK Kopec, N Joshi, H Cline-Fedewa, AV Wojcicki, JL Ray, BP Sullivan, JE Froehlich, BF Johnson, MJ Flick, JP Luyendyk |
Journal of Hepatology | 2016 |
Innate immunity, hemostasis and matrix remodeling: PTX3 as a link
A Doni, C Garlanda, A Mantovani |
Seminars in Immunology | 2016 |
Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia
Y Yang, H Tang |
Cellular and Molecular Immunology | 2016 |
Respiratory Antiviral Immunity and Immunobiotics: Beneficial Effects on Inflammation-Coagulation Interaction during Influenza Virus Infection
H Zelaya, S Alvarez, H Kitazawa, J Villena |
Frontiers in immunology | 2016 |
Platelets and coagulation in infection
RP Davis, S Miller-Dorey, CN Jenne |
IBMS BoneKEy | 2016 |
Innate generation of thrombin and intracellular oxidants in airway epithelium by allergen Der p 1
J Zhang, J Chen, K Allen-Philbey, CP Baruhupolage, T Tachie-Menson, SC Mangat, DR Garrod, C Robinson |
Journal of Allergy and Clinical Immunology | 2016 |
Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation
S Antoniak, JC Cardenas, LJ Buczek, FC Church, N Mackman, R Pawlinski |
Cardiology | 2016 |
Anticoagulation increases alveolar hemorrhage in mice infected with influenza A
K Tatsumi, S Antoniak, S Subramaniam, B Gondouin, SD Neidich, MA Beck, J Mickelson, DM Monroe, JA Bastarache, N Mackman |
Physiological Reports | 2016 |
Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice
S Antoniak, K Tatsumi, M Bode, S Vanja, JC Williams, N Mackman |
Journal of Innate Immunity | 2016 |
Mapping of a quantitative trait locus controlling susceptibility to Coxsackievirus B3-induced viral hepatitis
SA Wiltshire, J Marton, GA Leiva-Torres, SM Vidal |
Genes and Immunity | 2015 |
A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection
AC Hodowanec, RD Lee, KE Brady, W Gao, S Kincaid, J Plants, M Bahk, N Mackman, AL Landay, GD Huhn |
BMC Infectious Diseases | 2015 |
Glucose-6-Phosphate Dehydrogenase Enhances Antiviral Response through Downregulation of NADPH Sensor HSCARG and Upregulation of NF-κB Signaling
YH Wu, D Chiu, HR Lin, HY Tang, ML Cheng, HY Ho |
Viruses | 2015 |
Pulmonary C Fibers Modulate MMP-12 Production via PAR2 and Are Involved in the Long-Term Airway Inflammation and Airway Hyperresponsiveness Induced by Respiratory Syncytial Virus Infection
N Zang, J Zhuang, Y Deng, Z Yang, Z Ye, X Xie, L Ren, Z Fu, Z Luo, F Xu, E Liu, DS Lyles |
Journal of virology | 2015 |
Thrombin Inhibition with Dabigatran Protects against High-Fat Diet-Induced Fatty Liver Disease in Mice
AK Kopec, N Joshi, KL Towery, KM Kassel, BP Sullivan, MJ Flick, JP Luyendyk |
The Journal of pharmacology and experimental therapeutics | 2014 |
The Procoagulant Envelope Virus Surface: Contribution to Enhanced Infection
EL Pryzdial, MR Sutherland, W Ruf |
Thrombosis Research | 2014 |
Multiple roles of the coagulation protease cascade during virus infection
S Antoniak, N Mackman |
Blood | 2014 |
Roles of PAR1 and PAR2 in viral myocarditis
N Mackman, S Antoniak |
Thrombosis Research | 2014 |
Tissue factor, protease activated receptors and pathologic heart remodelling:
S Antoniak, E Sparkenbaugh, R Pawlinski |
Thrombosis and Haemostasis | 2014 |
Coagulation, Protease-Activated Receptors, and Viral Myocarditis
S Antoniak, N Mackman |
Journal of Cardiovascular Translational Research | 2013 |
Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model
L Aerts, MÈ Hamelin, C Rhéaume, S Lavigne, C Couture, W Kim, D Susan-Resiga, A Prat, NG Seidah, N Vergnolle, B Riteau, G Boivin |
PloS one | 2013 |
Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits
F Berri, VB Lê, M Jandrot-Perrus, B Lina, B Riteau |
Cellular and Molecular Life Sciences | 2013 |
Chronic HIV disease and activation of the coagulation system
JV Baker |
Thrombosis Research | 2013 |
Protease activated receptor-2 contributes to heart failure
S Antoniak, EM Sparkenbaugh, M Tencati, M Rojas, N Mackman, R Pawlinski |
PloS one | 2013 |
Cofactoring and Dimerization of Proteinase-Activated Receptors
H Lin, AP Liu, TH Smith, J Trejo |
2013 | |
Thrombin generation and atherosclerosis
J Kalz, H ten Cate, HM Spronk |
Journal of Thrombosis and Thrombolysis | 2013 |